Healthcare -
Biotechnology - NASDAQ - US
$ 8.54
-0.813 %
$ 1.78 B
Market Cap
-19.86
P/E
BCRX - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative BCRX - BioCryst Pharmaceuticals, Inc.
214 M
LAST VALUE
34.17%
2 YEAR CAGR
48.61%
5 YEAR CAGR
44.96%
10 YEAR CAGR